Category Archives: BioUtah News
Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results
Solid quarterly results highlighted by record revenue of $30.1 million, pre-tax income of $13.6 million and fully diluted EPS of $0.38
State Legislature Passes Statute regulating mandatory vaccination policies in the workplace.
The Utah legislature convened in special session this week regarding the issuance of an OSHA Emergency Temporary Standard (ETS) requiring the vaccination of all employees of companies with more than 100 employees.
AdvaMed Statement on Administration’s COVID-19 Testing Policy for Employers
AdvaMed released a statement from AdvaMedDx Executive Director Susan Van Meter on the testing policy regulation recently proposed by the Occupational Safety and Health Administration (OSHA) for employers with 100 or more employees under the Administration’s vaccine mandate.
PolarityTE Reports Third Quarter Financial Results and Provides Business Update
PolarityTE, Inc. recently provided a business update and reported financial results for the three and nine-month periods ended September 30, 2021.
Renalytix Convenes Expert Panel at VA Healthcare Summit
Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease
St. Joseph’s Health and Renalytix Partner to Advance Value-Based Kidney Health in New York
Partnership expands doctor and patient access to advanced prognosis and coordinated care management of early-stage diabetic kidney disease
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first patient has been dosed in a Phase 1 study evaluating its investigational agent DSP-0390, an emopamil-binding protein (EBP) inhibitor, for the treatment of patients with recurrent high-grade glioma. “Dosing the first patient in this study represents another […]
Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom
Company’s validated test available in the UK following implementation of UKHSA CTDA Regulations
New report shows more than 260 medicines in development to fight neurodegenerative diseases
PhRMA released a new report detailing the more than 260 medicines in development for 29 neurodegenerative diseases
Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial
Clene recently announced top-line data from RESCUE-ALS, a Phase 2 clinical trial evaluating CNM-Au8 as a disease modifying treatment for people with early amyotrophic lateral sclerosis (ALS).
Wilson Sonsini to open Salt Lake City office with trio of lawyers
Wilson Sonsini Goodrich & Rosati to open an office in Salt Lake City, becoming the latest major U.S. law firm to plant a flag in the tech-heavy region sometimes called “Silicon Slopes.”
Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans
Myriad Genetics announced financial results for its third quarter ended September 30, 2021 and provided an update on recent business performance and strategic transformation plans.
